Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | VHL |
| Variant | F119L |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | VHL F119L lies within the CCT complex-binding region and the aromatic tetrahedron core domain of the Vhl protein (UniProt.org, PMID: 23840444). F119L results in decreased Vhl protein stability as compared to wild-type, demonstrating increased misfolding and aggregation of Vhl protein in in-vitro assays (PMID: 23840444), and reduced solubility and decreased binding to Hif1a protein, and overexpression of P119L leads to a lethal phenotype in animal models (PMID: 30194449). |
| Associated Drug Resistance | |
| Category Variants Paths |
VHL mutant VHL inact mut VHL F119L |
| Transcript | NM_000551.4 |
| gDNA | chr3:g.10146528T>C |
| cDNA | c.355T>C |
| Protein | p.F119L |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000551.3 | chr3:g.10146528T>C | c.355T>C | p.F119L | RefSeq | GRCh38/hg38 |
| NM_000551 | chr3:g.10146528T>C | c.355T>C | p.F119L | RefSeq | GRCh38/hg38 |
| NM_000551.4 | chr3:g.10146528T>C | c.355T>C | p.F119L | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|